Network analysis and synthesis by mohammed arshad pdf CIRCUITS AND NETWORKS ANALYSIS AND SYNTHESIS 5 Download Circuits And Networks. Network Analysis And Synthesis By Mohammed Arshad Ab Short Reviews. Download PDF File. eBook Writing: This category includes topics like cookbooks, . On the workings of remote sensing and commercial importance. Download or any interactions with an active networks and has been Access to talk about.
|Language:||English, Spanish, Dutch|
|Genre:||Science & Research|
|Distribution:||Free* [*Register to download]|
Muhammad Arshad, Abdul Qayyum, Ghulam Abbas, Rizwan Haider,. Network analysis and synthesis Download network analysis and synthesis or read online . NETWORK ANALYSIS AND SYNTHESIS By MUHAMMAD ARSHAD Deptt. of Electrical & Electronics Engg. Ajay Kumar Garg Engg. College Ghaziabad, Uttar. Download pdf book by Muhammad Arshad – Free eBooks. Network analysis and synthesis by k. Deliberate and emergent strategies be conceived as two.
This engineered vasculature may need to mimic the intricate branching geometry of native microvasculature, referred to herein as vascular complexity, to efficiently deliver blood and recreate critical interactions between the vascular and perivascular cells as well as parenchymal tissues.
This review first describes the importance of vascular complexity in labs- and organs-on-chips, the biomechanical and biochemical signals needed to create and maintain a complex vasculature, and the limitations of current 2D, 2. We then critically review available strategies for design and biofabrication of complex vasculatures in cell culture platforms, labs- and organs-on-chips, and tissue engineering scaffolds, highlighting their advantages and disadvantages. Finally, challenges and future directions are outlined with the hope of inspiring researchers to create the reliable, efficient and sustainable tools needed for design and biofabrication of complex vasculatures.
A common goal for biofabrication is to recapitulate complex biological contexts e. In these cases, the material systems will need to: i present appropriate surface functionalities over a hierarchy of length scales e. And these requirements are not likely to be static but will vary over time and space, which will require capabilities of the material systems to dynamically respond, adapt, heal and reconfigure.
Here, we review recent advances in the use of electrically based fabrication methods to build material systems from biological macromolecules e. Electrical signals are especially convenient for fabrication because they can be controllably imposed to promote the electrophoresis, alignment, self-assembly and functionalization of macromolecules to generate hierarchically organized material systems.
Importantly, this electrically based fabrication with biologically derived materials i. We envision that electrobiofabrication will emerge as an important platform technology for organizing soft matter into dynamic material systems that mimic biology's complexity of structure and versatility of function.
Antimalarial An alarming situation of resistance against antimalarial drugs leads to the requirement of affordable treatment from medicinal plants [ 97 ]. Scientists have described antiplasmodium potential from variety of plant extracts [ 98 ].
In vitro studies to check the effects of lipo and hydrophilic extract from the bark of Fraxinus excelsior on the growth of asexual stages of Plasmodium falciparum suggest that it has significant inhibitory effects on the development of asexual stages of Plasmodium falciparum [ 99 ]. Antitoxoplasmosis Toxoplasmosis, an intracellular parasitic protozoan infection caused by Toxoplasma gondii, is usually asymptomatic but has serious clinical manifestations in immunocompromised individuals [ 100 ].
Herbal extracts that have important role in the regulation of immunity can serve as effective and secure medicine against toxoplasmosis [ 101 ].
Serious toxic effects associated with the application of antitoxoplasmosis drugs like sulfadiazine and pyrimethamine arouse the urgent need of safe and effective alternatives.
In vitro evaluations of antitoxoplasma activity of oleuropein and its metabolites isolated from Fraxinus rhynchophylla showed a good efficacy and higher selectivity as an anti-T. However, the results are not sufficient and should be approved by related tests along with clinical trials. The culpable compound should be subjected to isolation from extract and purified for further inquiry.
Antiaging Most of the plants that have high percentage of polyphenolic compounds have been widely used in cosmetics for their antiaging properties [ 102 ]. Esculetin from Fraxinus chinensis extract resulted in protective effects against photoaging via downregulating the MMP-1 mRNA in a dose-dependent fashion due to its free radical scavenging nature [ 48 ]. Other Biological Activities Some other biological activities of medically significant compounds isolated from Fraxinus species are as follows: diterpenes analogs from Fraxinus sieboldiana resulted in a prohibitory activity opposite to H5N1 avian influenza virus.
Inhibitory concentration IC50 reported to be 4.
Polyphenolic compounds as catechin, rutin, quercetin, and tannic acid from Fraxinus angustifolia bark and leaf extracts incorporated with different nanovesicles to increase the skin bioavailability found to be effective for their wound healing potential which is associated with their antioxidant and anti-inflammatory activity [ 31 ].
Fraxinus excelsior bark extract for its free radical scavenging activities and for tyrosinase elastase and collagenase prohibitory activities suggest its use in dermocosmetic industry [ 103 ].
Glucevia, an effective Fraxinus excelsior herbal extract that competently balances fructosamine and blood glucose concentrations, significantly augmented adiponectin-leptin ratio in obese and overweight older rats via oral administration of Glucevia immediately after sugar rich meals [ 104 , 105 ].
In vitro assessment of hydroxyframoside B isolated from ethanolic extract of stem bark of Fraxinus rhynchophylla provided an approach to decrease obesity via downregulating the pancreatic lipase activity thus restricting the absorption of lipid by pancreas [ 36 ]. Identification and isolation of lead structures from hydroethanolic extract for novel antidiabetic drug development are commended [ 107 ]. Drugs that work to decrease the elevated blood pressure in body by increasing the amount of urine and urinary sodium excretion are known as diuretics.
A study on herbal medicines has revealed that Fraxinus excelsior extract promotes diuresis and thus potentially can be used as hypotensive agent [ 109 ]. Conclusions and Future Perspectives This review reveals that Fraxinus plant is a valuable drug candidate with its potential anticarcinogenic, anti-inflammatory, antioxidative, and neuroprotective properties.
Various in vitro and in vivo studies results have demonstrated its several applications in biological systems. Stem bark, root bark, and leave extract of this plant have wide applications in traditional folk medicines since ancient times. Fraxinus plant derivative analogs along with pharmacodynamics and pharmacokinetics may also strengthen future advances.
Fraxinus plant extracts can serve as template for new drug design and synthesis of new compounds for various human diseases treatments. To date, most of the researchers do not figure out the chemical ingredients of the plant extracts.
Then, various pharmacological perspectives of Fraxinus plant such as proper dosage and clinical effectiveness are yet to be elucidated. There is a need to identify the toxicological limits for certain organs like liver and kidney.
The molecular mechanism and exact protein targets of potent bioactive molecules from Fraxinus plant also deserve to be further investigated. Conflicts of Interest The authors declare that there are no conflicts of interest. The authors would also like to acknowledge Higher Education Commission HEC , Pakistan, for providing access to related papers from various journals.
References Y. Luo, R. Cobb, and H. Rasul, F. Millimouno, W.
Ali Eltayb, M. Ali, J. Li, and X. Harvey, R. Edrada-Ebel, and R. Balunas and A. Atanasov, B. Waltenberger, and E. Newman and G. Newman, G. Cragg, and K. Sen and S. Engel, A. Falodun, J. Kragl, P. Langer, and B. Paul, R.
Gnanam, R. Jayadeepa, and L. Kuete, S. Alibert-Franco, K. Eyong et al. Mollataghi, E. Coudiere, A. Hadi et al. Son, M. Lee, G. Sung et al. Alaniia, K. Shalashvili, T. Sagareishvili, N. Kavtaradze, and M. Chatterjee, S. Bandyopadhyay, D. Ghosh, P. Ghosal, and B. Azab, A. Nassar, and A.
Fasano, S. Serini, N. Mondella et al. Howes, N. Perry, and P. He, G. Tan, G. Li et al. Sher, R. Bussmann, R. Hart, and H. Torres, O. Palomares, J. Quiralte, G. Pauli, R. Fernandez-Manjarres, P. Gerard, J. Dufour, C. Raquin, and N. Tanis and D. Hinsinger, M. Gaudeul, A. Couloux, J. Bousquet, and N. Zhang, Y. Liu, X. Chen, Z.
Yang, M. Zhu, and Y. Younis, M. Khan, M. Sajid, M. Majid, Z. Zahra, and N. Liang, W. Ju, S. Pei, Y. Tang, and Y. Moulaoui, C. Caddeo, M. Manca et al. Arce, M. Noguera et al. Bai, K.
He, A. Ibarra et al. Maghrani, N. Zeggwagh, A. Lemhadri, M. El Amraoui, J. Michel, and M. Von Kruedener, W. Schneider, and E. Ahn, E. Shin, Q. Liu et al. Choi, E. Wang, Y. Liu, G.
He, Y. Lv, and G. Thuong, Y. Pokharel, M. Lee et al. Xiao, Q. Song, S. Zhang, and L. Jiang, C. Jin, Y. Kim, H. Kim, W. Park, and H. Kim, J.